Forrest H. Fuller

Forrest H. Fuller has over 30 years of experience in business development and strategy roles in the pharmaceutical and biotechnology industries. Forrest most recently served as the Executive Vice President of Strategy and Business Development for portfolio companies in Japan at Catalys Pacific. Prior to that, Fuller held the position of Executive Director of Business Development at Travere Therapeutics. Forrest has also held various leadership roles at Organovo Holdings, Bionomics Ltd, S*BIO Pte Ltd, TargeGen Inc., Elitra Pharmaceuticals, Trega Biosciences Inc. (formerly known as Houghten Pharmaceuticals), and NPS Pharmaceuticals Inc. Throughout their career, Fuller has successfully led acquisitions, negotiated IP licenses, established partnerships, and positioned companies for successful investor financing.

Forrest H. Fuller has a Bachelor of Science (BS) degree in Chemistry from the University of Utah. Forrest then pursued a Doctor of Philosophy (PhD) in Biochemistry & Molecular Biology at Harvard University. Following their PhD, Fuller became a NATO Postdoctoral Fellow at McGill University. Later, they received a diploma from UC San Diego for completing the Executive Program for Scientists and Engineers. Additionally, Fuller holds certifications as a Certified Licensing Professional (CLP) from Certified Licensing Professionals, Inc. Forrest obtained these certifications in November 2008.